Business Description
Supha Pharmachem Ltd
ISIN : INE549S01036
Share Class Description:
BOM:539561: Ordinary SharesTotal Employee Number:
7Compare
Compare
Traded in other countries / regions
539561.India IPO Date
2016-01-12Description
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.07 | |||||
Debt-to-Equity | 10.34 | |||||
Debt-to-EBITDA | 64.05 | |||||
Interest Coverage | 1.13 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 0.45 | |||||
Beneish M-Score | 4.28 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -7.1 | |||||
3-Year EBITDA Growth Rate | 88.6 | |||||
3-Year EPS without NRI Growth Rate | 22.6 | |||||
3-Year Book Growth Rate | 107.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 49.67 | |||||
9-Day RSI | 52.56 | |||||
14-Day RSI | 51.92 | |||||
3-1 Month Momentum % | -32.61 | |||||
6-1 Month Momentum % | -62.65 | |||||
12-1 Month Momentum % | -76.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.07 | |||||
Quick Ratio | 0.89 | |||||
Days Inventory | 198.4 | |||||
Days Sales Outstanding | 558.4 | |||||
Days Payable | 419.93 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 2.94 | |||||
Operating Margin % | 1.07 | |||||
Net Margin % | 2.28 | |||||
EBITDA Margin % | 3.22 | |||||
FCF Margin % | -217.19 | |||||
OCF Margin % | -217.19 | |||||
ROE % | 18.45 | |||||
ROA % | 0.65 | |||||
ROIC % | 0.35 | |||||
3-Year ROIIC % | -0.06 | |||||
ROC (Joel Greenblatt) % | 8.58 | |||||
ROCE % | 26.09 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 2.63 | |||||
PE Ratio without NRI | 2.63 | |||||
Shiller PE Ratio | 0.08 | |||||
PEG Ratio | 0.02 | |||||
PS Ratio | 0.04 | |||||
PB Ratio | 0.28 | |||||
Price-to-Tangible-Book | 0.28 | |||||
EV-to-EBIT | 65.77 | |||||
EV-to-EBITDA | 65.69 | |||||
EV-to-Revenue | 2.12 | |||||
EV-to-FCF | -0.98 | |||||
Price-to-GF-Value | 0.22 | |||||
Price-to-Graham-Number | 0.18 | |||||
| Price-to-Net-Current-Asset-Value | 0.29 | |||||
Earnings Yield (Greenblatt) % | 1.52 | |||||
FCF Yield % | -3931.84 | |||||
Forward Rate of Return (Yacktman) % | -967.24 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Supha Pharmachem Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 5,268.983 | ||
| EPS (TTM) (₹) | 0.129 | ||
| Beta | 2.013 | ||
| 3-Year Sharpe Ratio | -1.42 | ||
| 3-Year Sortino Ratio | -1.58 | ||
| Volatility % | 82.31 | ||
| 14-Day RSI | 51.92 | ||
| 14-Day ATR (₹) | 0.014015 | ||
| 20-Day SMA (₹) | 0.3255 | ||
| 12-1 Month Momentum % | -76.34 | ||
| 52-Week Range (₹) | 0.25 - 1.8 | ||
| Shares Outstanding (Mil) | 881.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Supha Pharmachem Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Supha Pharmachem Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 4:1 Stock Split | 2024-07-05 | 12.18 (-12.09%) | ||
| 5:1 Stock Split | 2024-02-23 | 22.58 (-5.34%) | ||
| 2:1 Stock Split | 2023-09-01 | 28.48 (-0.89%) | ||
| 2.8:1 Stock Split | 2023-07-28 | 26.10 (-0.50%) |
Show
Entries
Supha Pharmachem Ltd Frequently Asked Questions
What is Supha Pharmachem Ltd(BOM:539561)'s stock price today?
The current price of BOM:539561 is ₹0.33. The 52 week high of BOM:539561 is ₹1.80 and 52 week low is ₹0.25.
When is next earnings date of Supha Pharmachem Ltd(BOM:539561)?
The next earnings date of Supha Pharmachem Ltd(BOM:539561) is .
Does Supha Pharmachem Ltd(BOM:539561) pay dividends? If so, how much?
Supha Pharmachem Ltd(BOM:539561) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Supha Pharmachem Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers